NattoPharma Market Update
Q3 revenue increases by more than 60% on a Q by Q comparisonOslo, Norway (19 November 2018) — NattoPharma reports operating revenues for the third quarter of 2018 of NOK 24,6 million, adjusted for non-product related revenue NOK 23,6 million. This represents growth of 61% compared to the third quarter of 2017. During the same period gross margin has developed positively to 45%, up from 42% in Q2, resulting in a year to date gross margin of 43%. all numbers in NOK million Q3 YTD 2018 2017 2018 2017Product Revenue 23,6 14,7 70,8